Evidence map›Paper›PMID 39131435›Full record

ArticleJournal of medical physics

Modeling of Gamma Index for Prediction of Pretreatment Quality Assurance in Stereotactic Body Radiation Therapy of the Liver.

Rose Kamal, Deepak Thaper, Gaganpreet Singh, Shambhavi Sharma, Navjeet, Arun Singh Oinam, Vivek Kumar

Abstract read
In one paragraph

Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rose KamalDepartment of Radiation Oncology, Amrita Institute of Medical Sciences and Research Centre, Faridabad, Haryana, India.
Deepak ThaperDepartment of Radiation Oncology, Amrita Institute of Medical Sciences and Research Centre, Faridabad, Haryana, India.
Gaganpreet SinghDepartment of Medical Physics, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India.
Shambhavi SharmaDepartment of Radiation Oncology, Institute of Liver and Biliary Sciences, New Delhi, India.
NavjeetDepartment of Radiation Oncology, Amrita Institute of Medical Sciences and Research Centre, Faridabad, Haryana, India.
Arun Singh OinamDepartment of Radiotherapy, Post Graduate Institute of Medical Education and Research, Regional Cancer Centre, Chandigarh, India.
Vivek KumarCentre for Medical Physics, Panjab University, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to develop a predictive model to evaluate pretreatment patient-specific quality assurance (QA) based on treatment planning parameters for stereotactic body radiation therapy (SBRT) for liver carcinoma. Materials and Methods: We retrospectively selected 180 cases of liver SBRT treated using the volumetric modulated arc therapy technique. Numerous parameters defining the plan complexity were calculated from the DICOM-RP (Radiotherapy Plan) file using an in-house program developed in MATLAB. Patient-specific QA was performed with global gamma evaluation criteria of 2%/2 mm and 3%/3 mm in a relative mode using the Octavius two-dimensional detector array. Various statistical tests and multivariate predictive models were evaluated. Results: The leaf speed (MI Conclusions: The model was potentially beneficial as an easy alternative to pretreatment QA in predicting the uncertainty in plan deliverability at the planning stage and could help reduce resources in busy clinics.

Indexed as

Gamma pass ratehepatocellular carcinomamodelingpretreatment quality assurancestereotactic body radiation therapyvolumetric modulated arc therapy

Identifiers

PMID39131435
PMCPMC11309143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.